Evidence map›Paper›PMID 21383136›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Chemistry of mycolactones, the causative toxins of Buruli ulcer.

Yoshito Kishi

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pharmacologic management ofExpert review of clinical pharmacology · 2020
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Natural products as mediators of disease.Natural product reports · 2017
    Review
  15. The chemistry and biology of mycolactones.Beilstein journal of organic chemistry · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Yoshito KishiDepartment of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, MA 02138, USA. kishi@chemistry.harvard.edu
Harvard University · US

Funding

SYNTHESIS OF ANTITUMOR NATURAL PRODUCTSR01CA022215 · NCI · HARVARD UNIVERSITY · PI KISHI, YOSHITO · 1985 to 2008
$2.4M
SYNTHESIS OF ANTITUTMOR NATURAL PRODUCTSR37CA022215 · NCI · HARVARD UNIVERSITY · PI KISHI, YOSHITO · 1986 to 2003
$1.9M
NCI NIH HHS CA 22215NCI NIH HHS R01 CA022215NCI NIH HHS R37 CA022215
6 · The paper itself

Abstract

Buruli ulcer is a severe and devastating skin disease caused by Mycobacterium ulcerans infection, yet it is one of the most neglected diseases. The causative toxin, referred to as mycolactone A/B, was isolated and characterized as a polyketide-derived macrolide in 1999. The current status of the mycolactone chemistry is described, highlighting the stereochemistry assignment of mycolactone A/B; total synthesis; the structure determination of mycolactone congeners from the human pathogen M. ulcerans, the frog pathogen Mycobacterium liflandii, and the fish pathogen Mycobacterium marinum; the structural diversity in the mycolactone class of natural products; the highly sensitive detection/structure-analysis of mycolactones; and some biological activity.

Indexed as

AnimalsAnuraBacterial ToxinsBuruli UlcerFish DiseasesFishesGuinea PigsHumansMacrolidesMolecular StructureMycobacterium ulceransBacterial ToxinsMacrolidesmycolactone

Identifiers

PMID21383136
PMCPMC3084064
OpenAlexW2038197441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.